T1	Participants 35 60	primary biliary cirrhosis
T2	Participants 146 177	Primary biliary cirrhosis (PBC)
T3	Participants 548 615	peripheral blood mononuclear cells (PBMC) from 42 patients with PBC
T4	Participants 934 970	Patients in the two treatment groups
T5	Participants 1053 1077	24 months in both groups
T6	Participants 1615 1649	patients treated with methotrexate
T7	Participants 1707 1734	colchicine-treated patients
